comparemela.com
Home
Live Updates
Dr McAndrew on the Implications of the PHERGain Study in HER2+ Breast Cancer : comparemela.com
Dr McAndrew on the Implications of the PHERGain Study in HER2+ Breast Cancer
Nicholas P. McAndrew, MD, MSCE, discusses the implications of the phase 2 PHERGain study of chemotherapy de-escalation in patients with HER2-positive early breast cancer.
Related Keywords
California ,
United States ,
Los Angeles ,
Nicholasp Mcandrew ,
,
University Of California ,
Ucla Health Jonsson Comprehensive Cancer Center ,
Onclive Tv ,
Neoadjuvant Her2 ,
Breast Cancer ,
Nct03161353 ,
comparemela.com © 2020. All Rights Reserved.